Irritable Bowel Syndrome (IBS) and colon cancer both affect the digestive system and can present with similar symptoms like abdominal pain, bloating, and changes in bowel movements. However, they are ...

Irritable bowel syndrome with constipation is referred to as IBS-C. People with IBS-C experience constipation-related abdominal pain. This is usually accompanied by a change in the frequency or form ...

Pregnancy causes hormonal changes which may trigger or worsen IBS symptoms. If you have IBS and you’re planning on becoming pregnant, making lifestyle and dietary changes can help. Women are more than ...

Q: Why do I have irritable bowel syndrome? A: People with irritable bowel syndrome, or IBS, suffer from recurrent abdominal pain related to having bowel movements — whether it’s diarrhea, constipation ...

An estimated 5% to 10% of the world population is affected by irritable bowel syndrome (IBS), which accounts for 20% to 40% of all visits to gastroenterologists. Patients with IBS have triple the odds ...

One of the most, well, irritating parts about irritable bowel syndrome with constipation (IBS-C) is the abdominal pain. The sharp, stabbing sensation can stop you in your tracks — and make it tough to ...

Digestive issues like bloating, constipation are often ignored, but persistent symptoms can indicate bowel cancer. Early ...

FDA has announced it has approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults, according to a news release. Linzess ...

Irritable bowel syndrome (IBS) is the most common gastrointestinal condition worldwide, affecting about 1 in 10 people, primarily women. Those who have it suffer abdominal pains and also often develop ...

NEW YORK (Reuters Health) - Long-term constipation doesn't raise risk for colon and rectal cancers according to a new analysis of the existing evidence. Past studies had suggested a possible ...

The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 years and older, the agency announced Wednesday. The decision makes the ...